PR Newswire
LONDON, Feb. 17, 2026
LONDON, Feb. 17, 2026 /PRNewswire/ — The global scar treatment market is growing robustly, expected to be valued at around US$ 23.0 billion in 2026 and projected to reach US$ 49.2 billion by 2033, with a CAGR of 11.5% in the coming years. This expansion comes from rising aesthetic awareness, advances in minimally invasive therapies, and broader acceptance of scar management solutions. Demand is bolstered by both topical products and advanced procedures like lasers, which help consumers and clinicians improve skin appearance and function. Market dynamics also reflect stronger healthcare infrastructure and increasing adoption of digital health tools that support treatment planning and outcomes tracking.
https://mma.prnewswire.com/media/2876873/Persistence_Market_Research_Logo.jpg
Surge in Aesthetic and Cosmetic Treatments Fueled by Consumer Awareness
One of the primary drivers of the scar treatment market is the global rise in aesthetic and cosmetic procedures. As patients become more appearance-conscious and seek professional solutions for scar improvement, demand for effective scar management products and services increases. According to industry data, approximately 38 million aesthetic procedures were performed worldwide in 2024, up significantly from 2020, reflecting heightened interest in treatments that improve skin appearance.
Topical products, including silicone-based gels, sheets, and serums, are especially popular due to their non-invasive nature, ease of use, and proven effectiveness in reducing scar height, pigmentation, and stiffness. These products support combination therapies and are often the first choice for post-surgical or traumatic scars, driving broad adoption across clinical and homecare settings.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 & 𝐂𝐡𝐞𝐜𝐤 𝐭𝐡𝐞 𝐋𝐚𝐭𝐞𝐬𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: https://www.persistencemarketresearch.com/samples/3471
Key Highlights:
- The global scar treatment market is projected to reach US$ 49.2 billion by 2033, expanding at a CAGR of 11.5%.
- Rising demand for aesthetic procedures and post-surgical scar management continues to accelerate market growth worldwide.
- Topical products lead with 64.3% market share, driven by strong clinical validation and non-invasive use.
- Laser-based and energy-driven treatments represent the fastest-growing segment due to technological advancements and higher efficacy.
- North America holds the dominant regional share, supported by advanced dermatology infrastructure and high consumer spending.
- Asia Pacific is the fastest-growing region, fueled by urbanization, rising disposable incomes, and expanding cosmetic treatment adoption.
- The North America scar treatment market is set to grow from US$5.2 Bn in 2025 to US$10.3 Bn by 2032
Technological Advancements Propel Treatment Efficacy
Advancements in scar treatment technology are another significant growth engine for the market. Minimally invasive procedures, such as fractional CO2 and excimer lasers, provide deeper tissue remodeling and enhanced collagen stimulation, yielding visible improvement for challenging scars. These technologies appeal to both dermatologists and patients due to faster healing times and improved cosmetic results compared with traditional approaches.
Further innovation includes combined treatment protocols, integrating topical formulations with energy-based devices, which optimize outcomes for conditions such as hypertrophic scars and keloids. These developments support clinicians in tailoring treatments to patient-specific needs, boosting efficacy and satisfaction.
The market is experiencing significant growth due to the increasing demand for non-invasive procedures to address scars. This trend is driven by the desire for minimal downtime and fewer risks associated with surgical interventions. Additionally, the adoption of ambulatory surgery centers is on the rise, enabling more accessible and cost-effective treatment options for patients. However, the high cost of scar treatment procedures remains a notable challenge for market growth.
Despite this, companies can capitalize on the market’s potential by offering affordable, effective solutions and expanding their reach to ambulatory surgery centers. By focusing on innovation and patient-centric care, market players can differentiate themselves and meet the growing demand for non-invasive scar treatments.
Key Highlight: BIOCORNEUM Expands Product Line with Proprietary Bruise Care System
- A standout development in October 2025 highlights how Sientra’s BIOCORNEUM brand continues to expand its scar and skin recovery portfolio with the introduction of a new proprietary bruise care system alongside an expanded range of scar treatment products designed to meet diverse patient needs. The announcement emphasizes BIOCORNEUM’s leadership in silicone scar treatment and its commitment to innovation in post-procedure recovery care.
- The expanded product line is positioned to support aesthetic providers and patients with comprehensive recovery solutions. BIOCORNEUM, known for its silicone-based scar treatment formulations that include SPF protection, is broadening its offerings to address both scar management and bruise recovery within a unified system. The proprietary bruise care system is presented as a complementary addition aimed at enhancing post-procedure outcomes.
- According to the release, the expanded scar treatment range is designed to «fit every need,» reinforcing the brand’s focus on versatility and clinical applicability across different scar types and recovery scenarios. The development reflects continued investment in product innovation within the aesthetic and dermatologic care segment.
This move signals growing integration between scar treatment and post-procedure skin recovery solutions within the medical aesthetics market. The expansion strengthens BIOCORNEUM’s positioning as a comprehensive recovery-care brand and underscores the trend toward bundled, procedure-adjacent skincare systems that support both providers and patients.
𝐆𝐞𝐭 𝐚 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐕𝐢𝐞𝐰 Ask our Expert: https://www.persistencemarketresearch.com/request-customization/3471
By Product, Topical Products Dominate While Laser-Based Treatments Gain Rapid Momentum
Topical products account for 64.3% of the global scar treatment market, making them the leading segment due to their non-invasive application, clinical validation, and widespread accessibility. Silicone-based gels and sheets remain the preferred first-line therapy for post-surgical and traumatic scars, supported by strong dermatologist recommendations and over-the-counter availability. Their affordability and suitability for home use further reinforce segment dominance across both developed and emerging markets. A notable development includes the increased adoption of combination therapies integrating topical silicone products with fractional laser procedures, enhancing treatment outcomes and accelerating recovery timelines.
Regional Insights: North America is a Dominant Market For Scar Treatments
North America holds the largest share of 40.5% the scar treatment market, backed by established healthcare infrastructure, high consumer awareness, and strong adoption of dermatological procedures. The U.S. market, in particular, benefits from widespread clinic networks and proactive aesthetic spending, which support both device-based and topical treatment uptake.
Asia-Pacific is the fastest-growing region, driven by expanding healthcare facilities, rising disposable incomes, and increasing investments in cosmetic and clinical dermatology. Countries such as China and India show rapid urbanization and growing demand for aesthetic care, making them key contributors to future market growth. Europe maintains steady demand supported by clinical innovation and high aesthetic procedure volumes, while Latin America and the Middle East grow via rising interest in scar management and advanced skin treatments.
𝐂𝐥𝐢𝐜𝐤 𝐭𝐨 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 & 𝐒𝐭𝐚𝐫𝐭 𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠: https://www.persistencemarketresearch.com/checkout/3471
Market Segmentation
By Product
- Topical products
- Gels
- Creams
- Oils
- Sheets
- Laser products
- CO2 Laser
- Excimer Laser
- Pulsed dyed Laser
- Surface treatment products
- Injectable products
By Application
- Atrophic scars
- Hypertrophic Scars and Keloids
- Contractures
- Stretch Marks
By End-user
- Hospitals
- Clinics
- Pharmacies & Drug stores
- E-commerce
Key Players and Business Strategies
Leading companies in the scar treatment market include Smith+Nephew plc, HRA Pharma, Sonoma Pharmaceuticals, Inc., CCA Industries, Inc., Cynosure, Inc., Avita Medical Limited, Mölnlycke Health Care AB, Pacific World Corporation, Shanghai Fosun Pharmaceuticals Ltd., and Beijing Toplaser Technology Company Limited.
– Smith+Nephew plc invests in clinical research and product efficacy to strengthen its scar management portfolio.
– HRA Pharma focuses on specialty formulations with proven scar reduction performance.
– Sonoma Pharmaceuticals and others enhance distribution and marketing channels to expand global reach and accessibility.
Strategies emphasize personalized treatment options, integration with digital treatment planning tools, and partnerships with clinics and aesthetic practitioners to drive adoption and treatment success.
Related Reports:
OTC Scar Treatment Market by Product (Gels, Ointments, Oils, Sheets, Sprays, and Others), by Application (Atrophic Scars, Hypertrophic Scars and Keloids, Contractures, Burns, and Stretch Marks), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Analysis from 2026 to 2033.
Atrophic Scar Treatment Market by Product Type (Topical, Laser, Surface treatment, Injectable), Distribution Channel, and Regional Analysis from 2026 to 2033
Scar Treatment Market in North America by Product (Topical, Laser, Injectable, Others), Application (Atrophic scars, Hypertrophic Scars and Keloids, Contractures, Stretch Marks), by End-user, and Country Analysis from 2025 to 2032
Combination Treatments For Scars Market Combination Treatments for Scars Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 – 2025
Stretch Marks Treatment Market by Treatment(Topical Medications, Procedural Treatments), By Stretch Mark Type( Striae atrophicans, Striae gravidarum , Striae distensae , striae rubrae , Striae albae , Striae nigra , Striae caerulea ), By End User( Hospitals, Dermatology Clinics, Aesthetic Clinics, Wellness and Spa Centers, Home Care Settings) and Regional Analysis
Keloid Treatment Market by Treatment Type (Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injections, Others), End-user (Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, Others), and Regional Analysis, 2026-2033
Organic Mascara Market by Application (Volumizing, Lengthening, Curling, Others), Product Type (Liquid, Gel, Cream), Nature (Regular, Waterproof), Distribution Channel (Online, Offline), and Regional Analysis for 2026 – 2033
Madagascar Periwinkle Extract Market Madagascar Periwinkle Extract Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 2018 – 2028
Croscarmellose Sodium Market by Raw Material (Refined Wood Pulp, Cotton Linters), End-user (Pharmaceutical & Nutraceutical, Food & Beverage, Cosmetics & Personal Care), and Regional Analysis for 2025 – 2032
Miscarriage Testing Market by Technology (Chromosomal Microarray Analysis (CMA), Next-Generation Sequencing (NGS), Conventional Karyotyping, Fluorescence in Situ Hybridization), Application (Recurrent Pregnancy Loss (RPL), First-Time Sporadic, Stillbirth Analysis, Threatened Miscarriage Evaluation), End-User (Hospitals, Fertility Clinics, Research and Academic Institutions), and Regional Analysis for 2026-2033
About Persistence Market Research:
At Persistence Market Research, we are pioneers in Market Research and Consulting, bringing you the most dynamic insights into market trends, consumer behaviors, and competitive intelligence! For over a decade, we’ve been at the forefront of delivering game-changing analytics and research that drive businesses toward growth.
Our extensive market report database is a go-to resource for Fortune 500 companies, savvy business investors, media and entertainment channels, and academic institutions, empowering them to navigate the global and regional business landscape with confidence. With thousands of statistics and in-depth analyses covering over 20 diverse industries across 25 major countries, we provide the insights you need to succeed in today’s competitive environment.
ContactRitika KhandelwalPersistence Market ResearchSecond Floor, 150 Fleet Street, London, EC4A 2DQ+44 203-837-5656United KingdomUSA Phone – +1 646-878-6329Email: [email protected]
Logo: https://mma.prnewswire.com/media/2876873/Persistence_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/scar-treatment-market-to-reach-us-49-2-bn-by-2033-expands-amid-rising-aesthetic-demand-and-technological-innovation–persistence-market-research-302689551.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…